In this episode, Drs. Matt Martinez and Ahmad Masri discuss the
recent approval by the FDA of the cardiac myosin inhibitor
Mavacamten for the treatment of hypertrophic cardiomyopathy, and
mechanisms of action.
About the Podcast
This occasional series from the American College of Cardiology offers the latest in clinical education and features an exploration of current research and interviews with cardiovascular experts.